-The Economic Times NEW DELHI: Civil society group All India Drug Action Network (AIDAN) has sent legal notices to Niti Aayog CEO and secretaries to the health ministry, department of pharmaceuticals and department of industrial policy and promotion over their talks to cut powers of the National Pharmaceutical Pricing Authority. The group has termed the move “anti-national” and “anti-people”, adding that it affects an ongoing case at the Supreme Court over various...
More »SEARCH RESULT
Now, healing with 'qualified' quacks -R Prasad
-The Hindu The State has taken the lead in providing some essential and basic health-care training to these informal providers. In West Bengal, nearly 3,000 quacks — informal health-care providers with no formal medical education — are to be trained for six months. The crash course in medicine, and to be conducted by 130 trained nurses, is to begin from December 1. The objective is to provide these informal providers with a minimum...
More »Out of essentials list, prices of 100 drugs may increase by 10% -Sushmi Dey
-The Times of India NEW DELHI: Prices of around 100 medicines, including those for Alzheimer's, diabetes and hypertension, could rise by up to 10% after they were removed from the national list of essential medicines. Though the move is likely to impact consumers, it comes as a relief to drug makers reeling under stringent price regulation for over a year. Overruling a previous order by the drug price regulator, the Centre has...
More »Leveraging primary care -Poonam Khetrapal Singh
-The Hindu Health-care workers at the primary level must be given the knowledge and skills to provide NCD and associated risk factor care. Noncommunicable diseases (NCD) such as diabetes, respiratory diseases, cancer and heart diseases are taking a severe toll on public health across the WHO South-East Asia Region. Approximately 8.5 million lives, many of them premature, are lost each year due to NCDs, making them the region’s leading cause of death...
More »A disaster in the making -A Rangarajan
-Frontline Medecins Sans Frontieres warns that the free or regional trade agreements that are being negotiated, which seek to strengthen current patent regimes, are a potential threat to the developing world’s access to life-saving drugs, which it sources mostly from India. WHEN NELSON MANDELA’S GOVERNMENT passed the Medicines and Related Substances Control Act in 1997 to make medicines more accessible to the poor, 39 big pharmaceutical companies filed law suits in...
More »